{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:17:22Z","timestamp":1790007442133,"version":"4.0.1"},"reference-count":138,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","cghjournal.org","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.cgh.2017.05.041","type":"journal-article","created":{"date-parts":[[2017,6,7]],"date-time":"2017-06-07T17:45:15Z","timestamp":1496857515000},"page":"162-177.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["New Developments in Hepatorenal Syndrome"],"prefix":"10.1016","volume":"16","author":[{"given":"Ayse L.","family":"Mindikoglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Pappas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2017.05.041_bib1","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1681\/ASN.V4101735","article-title":"Hepatorenal syndrome: emerging perspectives of pathophysiology and therapy","volume":"4","author":"Epstein","year":"1994","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.cgh.2017.05.041_bib2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/gut.2010.236133","article-title":"Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis","volume":"60","author":"Wong","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2017.05.041_bib3","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.20687","article-title":"MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation","volume":"41","author":"Alessandria","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2017.05.041_bib4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00007691-198306000-00002","article-title":"Decreased rate of creatinine production in patients with hepatic disease: implications for estimation of creatinine clearance","volume":"5","author":"Cocchetto","year":"1983","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.cgh.2017.05.041_bib5","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/lt.22121","article-title":"Gender disparity in liver transplant waiting-list mortality: the importance of kidney function","volume":"16","author":"Mindikoglu","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2017.05.041_bib6","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/0002-9343(87)90156-2","article-title":"Unpredictability of clinical evaluation of renal function in cirrhosis. Prospective study","volume":"82","author":"Papadakis","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.cgh.2017.05.041_bib7","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1053\/ajkd.2003.50035","article-title":"Assessing renal function in cirrhotic patients: problems and pitfalls","volume":"41","author":"Sherman","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cgh.2017.05.041_bib8","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMra054415","article-title":"Assessing kidney function\u2013measured and estimated glomerular filtration rate","volume":"354","author":"Stevens","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2017.05.041_bib9","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/hep.26556","article-title":"Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis","volume":"59","author":"Mindikoglu","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2017.05.041_bib10","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/clinchem\/24.2.392","article-title":"Bilirubin interference with the kinetic Jaff\u00e9 method for serum creatinine","volume":"24","author":"Daugherty","year":"1978","journal-title":"Clin Chem"},{"key":"10.1016\/j.cgh.2017.05.041_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0016-5085(17)33774-5","article-title":"Serum creatinine in female patients with cirrhosis unfairly bias liver transplant wait list ranking: implications for elimination of gender disparities in access to orthotopic liver transplantation","volume":"152","author":"Mindikoglu","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2017.05.041_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.cgh.2017.05.041_bib13","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1093\/ndt\/gfg349","article-title":"A\u00a0comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate","volume":"18","author":"Hoek","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cgh.2017.05.041_bib14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2017.05.041_bib15","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/hep.28891","article-title":"Development and validation of a mathematical equation to estimate glomerular filtration rate in cirrhosis: the royal free hospital cirrhosis glomerular filtration rate","volume":"65","author":"Kalafateli","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2017.05.041_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/00365510410003723","article-title":"Calculation of glomerular filtration rate expressed in mL\/min from plasma cystatin C values in mg\/L","volume":"64","author":"Larsson","year":"2004","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.cgh.2017.05.041_bib17","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A\u00a0more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2017.05.041_bib18","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1373\/clinchem.2006.077180","article-title":"Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values","volume":"53","author":"Levey","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.cgh.2017.05.041_bib19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate","volume":"145","author":"Levey","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2017.05.041_bib20","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A\u00a0new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2017.05.041_bib21","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.cgh.2015.06.021","article-title":"Estimation of glomerular filtration rate in patients with cirrhosis by using new and conventional filtration markers and dimethylarginines","volume":"14","author":"Mindikoglu","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2017.05.041_bib22","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/j.ajkd.2007.11.018","article-title":"Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD","volume":"51","author":"Stevens","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cgh.2017.05.041_bib23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/jgh.13446","article-title":"Comparison of creatinine and cystatin formulae with 51 chromium-ethylenediaminetetraacetic acid glomerular filtration rate in patients with decompensated cirrhosis","volume":"32","author":"Cholongitas","year":"2017","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2017.05.041_bib24","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/hep.26886","article-title":"Creatinine- versus cystatine C-based equations in assessing the renal function of candidates for liver transplantation with cirrhosis","volume":"59","author":"De Souza","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2017.05.041_bib25","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1002\/hep.26704","article-title":"Glomerular filtration rate equations for liver-kidney transplantation in patients with cirrhosis: validation of current recommendations","volume":"59","author":"Francoz","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2017.05.041_bib26","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/lt.22128","article-title":"Inaccuracies of creatinine and creatinine-based equations in candidates for liver transplantation with low creatinine: impact on the model for end-stage liver disease score","volume":"16","author":"Francoz","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2017.05.041_bib27","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1111\/j.1600-6143.2012.04190.x","article-title":"Simultaneous liver-kidney transplantation summit: current state and future directions","volume":"12","author":"Nadim","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cgh.2017.05.041_bib28","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1053\/jhep.2002.33160","article-title":"Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation","volume":"35","author":"Nair","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2017.05.041_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinbiochem.2004.09.025","article-title":"Cystatin C as a marker of GFR\u2013history, indications, and future research","volume":"38","author":"Filler","year":"2005","journal-title":"Clin Biochem"},{"key":"10.1016\/j.cgh.2017.05.041_bib30","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jhep.2014.12.029","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites","volume":"62","author":"Angeli","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2017.05.041_bib31","first-page":"1310","article-title":"Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis","volume":"56","author":"Salerno","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2017.05.041_bib32","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"},{"key":"10.1016\/j.cgh.2017.05.041_bib33","first-page":"1","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.cgh.2017.05.041_bib34","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jhep.2015.10.019","article-title":"Management of the critically ill patient with cirrhosis: a multidisciplinary perspective","volume":"64","author":"Nadim","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2017.05.041_bib35","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1111\/ajt.13790","article-title":"Protecting the kidney in liver transplant candidates: practice-based recommendations from the American Society of Transplantation Liver and Intestine Community of Practice","volume":"16","author":"O'Leary","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cgh.2017.05.041_bib36","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/hep.25735","article-title":"Association of AKI with mortality and complications in hospitalized patients with cirrhosis","volume":"57","author":"Belcher","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2017.05.041_bib37","series-title":"The Kidney in Liver Disease","first-page":"75","article-title":"Hepatorenal syndrome","author":"Epstein","year":"1996"},{"key":"10.1016\/j.cgh.2017.05.041_bib38","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0140-6736(71)90435-1","article-title":"Renal and intrarenal blood-flow in cirrhosis of the liver","volume":"2","author":"Kew","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2017.05.041_bib39","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1159\/000363584","article-title":"A\u00a0pilot study to evaluate renal hemodynamics in cirrhosis by simultaneous glomerular filtration rate, renal plasma flow, renal resistive indices and biomarkers measurements","volume":"39","author":"Mindikoglu","year":"2014","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.cgh.2017.05.041_bib40","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/hep.510280510","article-title":"Reduction of renal cortical blood flow assessed by Doppler in cirrhotic patients with refractory ascites","volume":"28","author":"Rivolta","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2017.05.041_bib41","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0002-9343(70)80073-0","article-title":"Renal failure in the patient with cirrhosis. The role of active vasoconstriction","volume":"49","author":"Epstein","year":"1970","journal-title":"Am J Med"},{"key":"10.1016\/j.cgh.2017.05.041_bib42","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000355540","article-title":"Current concepts in the diagnosis and classification of renal dysfunction in cirrhosis","volume":"38","author":"Mindikoglu","year":"2013","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.cgh.2017.05.041_bib43","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jhep.2012.03.015","article-title":"Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis","volume":"57","author":"Fagundes","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2017.05.041_bib44","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.26980","article-title":"Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury","volume":"60","author":"Belcher","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2017.05.041_bib45","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0016-5085(17)33534-5","article-title":"Robust metabolomic signature is associated with altered renal hemodynamics in patients with cirrhosis","volume":"152","author":"Mindikoglu","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2017.05.041_bib46","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2165\/00003088-197904030-00003","article-title":"Use of serum creatinine concentrations to determine renal function","volume":"4","author":"Bjornsson","year":"1979","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.cgh.2017.05.041_bib47","unstructured":"Organ Procurement and Transplantation Network Policies. Available at: https:\/\/optn.transplant.hrsa.gov\/media\/1200\/optn_policies.pdf#nameddest=Policy_09. Accessed: January 1,\u00a02017."},{"key":"10.1016\/j.cgh.2017.05.041_bib48","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa0801209","article-title":"Hyponatremia and mortality among patients on the liver-transplant waiting list","volume":"359","author":"Kim","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2017.05.041_bib49","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1053\/he.2000.5852","article-title":"A\u00a0model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts","volume":"31","author":"Malinchoc","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2017.05.041_bib50","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1600-6143.2007.01666.x","article-title":"Female liver transplant recipients with the same GFR as male recipients have lower MELD scores\u2013a systematic bias","volume":"7","author":"Cholongitas","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cgh.2017.05.041_bib51","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000181400","article-title":"A\u00a0proposed mechanism for reduced creatinine excretion in severe chronic renal failure","volume":"21","author":"Mitch","year":"1978","journal-title":"Nephron"},{"key":"10.1016\/j.cgh.2017.05.041_bib52","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jhep.2011.03.012","article-title":"Diagnosis, treatment and survival of patients with hepatorenal syndrome: a survey on daily medical practice","volume":"55","author":"Salerno","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2017.05.041_bib53","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.cgh.2006.08.007","article-title":"Natural history of patients hospitalized for management of cirrhotic ascites","volume":"4","author":"Planas","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2017.05.041_bib54","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/hep.22605","article-title":"Acute kidney injury in cirrhosis","volume":"48","author":"Garcia-Tsao","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2017.05.041_bib55","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/cc2872","article-title":"Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group","volume":"8","author":"Bellomo","year":"2004","journal-title":"Crit Care"},{"key":"10.1016\/j.cgh.2017.05.041_bib56","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/lt.23384","article-title":"Impact of the etiology of acute kidney injury on outcomes following liver transplantation: acute tubular necrosis versus hepatorenal syndrome","volume":"18","author":"Nadim","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2017.05.041_bib57","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/gutjnl-2011-301255","article-title":"Acute kidney injury in decompensated cirrhosis","volume":"62","author":"Tsien","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2017.05.041_bib58","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.cgh.2016.09.156","article-title":"Validation of a staging system for acute kidney injury in patients with cirrhosis and association with acute-on-chronic liver failure","volume":"15","author":"Huelin","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2017.05.041_bib59","series-title":"Renal physiology","first-page":"31","article-title":"Glomerular filtration and renal blood flow","author":"Koeppen","year":"2007"},{"key":"10.1016\/j.cgh.2017.05.041_bib60","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/archinte.1997.00440260132016","article-title":"Renal blood flow detection with Doppler ultrasonography in patients with hepatic cirrhosis","volume":"157","author":"Celebi","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cgh.2017.05.041_bib61","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1172\/JCI102539","article-title":"Renal function as a factor in fluid retention in patients with cirrhosis of the liver","volume":"30","author":"Leslie","year":"1951","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cgh.2017.05.041_bib62","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/153537020623100108","article-title":"Accumulation of symmetric dimethylarginine in hepatorenal syndrome","volume":"231","author":"Lluch","year":"2006","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.cgh.2017.05.041_bib63","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1054\/clnu.2002.0612","article-title":"The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA)","volume":"22","author":"Nijveldt","year":"2003","journal-title":"Clin Nutr"},{"key":"10.1016\/j.cgh.2017.05.041_bib64","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1054\/clnu.2002.0614","article-title":"The asymmetrical dimethylarginine (ADMA)-multiple organ failure hypothesis","volume":"22","author":"Nijveldt","year":"2003","journal-title":"Clin Nutr"},{"key":"10.1016\/j.cgh.2017.05.041_bib65","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM199808203390807","article-title":"Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis","volume":"339","author":"Martin","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2017.05.041_bib66","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1054\/clnu.2002.0613","article-title":"Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality","volume":"22","author":"Nijveldt","year":"2003","journal-title":"Clin Nutr"},{"key":"10.1016\/j.cgh.2017.05.041_bib67","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0140-6736(92)90865-Z","article-title":"Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure","volume":"339","author":"Vallance","year":"1992","journal-title":"Lancet"},{"issue":"Suppl 12","key":"10.1016\/j.cgh.2017.05.041_bib68","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1097\/00005344-199204002-00018","article-title":"Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis","volume":"20","author":"Vallance","year":"1992","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.cgh.2017.05.041_bib69","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/pgmj.68.803.697","article-title":"Endothelial regulation of vascular tone","volume":"68","author":"Vallance","year":"1992","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.cgh.2017.05.041_bib70","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jhep.2004.03.016","article-title":"Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis","volume":"41","author":"Lluch","year":"2004","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2017.05.041_bib71","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/hep.20579","article-title":"The human liver clears both asymmetric and symmetric dimethylarginine","volume":"41","author":"Siroen","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2017.05.041_bib72","doi-asserted-by":"crossref","first-page":"7214","DOI":"10.3748\/wjg.14.7214","article-title":"Transjugular intrahepatic portosystemic shunt-placement increases arginine\/asymmetric dimethylarginine ratio in cirrhotic patients","volume":"14","author":"Siroen","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.05.041_bib73","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/0148607108321702","article-title":"The prominent role of the liver in the elimination of asymmetric dimethylarginine (ADMA) and the consequences of impaired hepatic function","volume":"32","author":"Richir","year":"2008","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.cgh.2017.05.041_bib74","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2362.2007.01814.x","article-title":"ADMA correlates with portal pressure in patients with compensated cirrhosis","volume":"37","author":"Vizzutti","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cgh.2017.05.041_bib75","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/hep.21491","article-title":"Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis","volume":"45","author":"Mookerjee","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2017.05.041_bib76","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/MEG.0b013e328308bb9c","article-title":"Cirrhotics admitted to intensive care unit: the impact of acute renal failure on mortality","volume":"21","author":"Cholongitas","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2017.05.041_bib77","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/hep.26687","article-title":"Type-1 hepatorenal syndrome associated with infections in cirrhosis: natural history, outcome of kidney function, and survival","volume":"59","author":"Barreto","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2017.05.041_bib78","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1002\/hep.21920","article-title":"Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure","volume":"46","author":"Thabut","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2017.05.041_bib79","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hep.23283","article-title":"Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome","volume":"51","author":"Nazar","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2017.05.041_bib80","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ki.2014.338","article-title":"Renal dysfunction in cirrhosis is not just a vasomotor nephropathy","volume":"87","author":"Adebayo","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.cgh.2017.05.041_bib81","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/ki.2013.78","article-title":"Bile cast nephropathy is a common pathologic finding for kidney injury associated with severe liver dysfunction","volume":"84","author":"van Slambrouck","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.cgh.2017.05.041_bib82","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1053\/jhep.2001.25089","article-title":"Partially reversible renal tubular damage in patients with obstructive jaundice","volume":"33","author":"Bairaktari","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2017.05.041_bib83","doi-asserted-by":"crossref","first-page":"736","DOI":"10.5114\/aoms.2011.24148","article-title":"Life-threatening hypophosphataemia in a cirrhotic patient with jaundice","volume":"7","author":"Moutzouri","year":"2011","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.cgh.2017.05.041_bib84","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2010.11.020","article-title":"Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics","volume":"55","author":"Boyer","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2017.05.041_bib85","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cgh.2016.07.016","article-title":"Terlipressin improves renal function and reverses hepatorenal syndrome in patients with systemic inflammatory response syndrome","volume":"15","author":"Wong","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2017.05.041_bib86","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2017.05.041_bib87","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MEG.0b013e3283435d76","article-title":"Prevention of hepatorenal syndrome in patients with cirrhosis and ascites: a pilot randomized control trial between pentoxifylline and placebo","volume":"23","author":"Tyagi","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2017.05.041_bib88","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1053\/j.gastro.2010.01.040","article-title":"Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis","volume":"138","author":"Lebrec","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2017.05.041_bib89","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2010.05.004","article-title":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis","volume":"53","author":"Gin\u00e8s","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2017.05.041_bib90","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1053\/j.ajkd.2011.12.032","article-title":"Hepatorenal syndrome: a severe, but treatable, cause of kidney failure in cirrhosis","volume":"59","author":"Fagundes","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cgh.2017.05.041_bib91","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1053\/j.ajkd.2015.09.013","article-title":"Pathogenesis of hepatorenal syndrome: implications for therapy","volume":"67","author":"Durand","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cgh.2017.05.041_bib92","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.28396","article-title":"Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: a randomized controlled study","volume":"63","author":"Cavallin","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2017.05.041_bib93","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/hep.22853","article-title":"Management of adult patients with ascites due to cirrhosis: an update","volume":"49","author":"Runyon","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2017.05.041_bib94","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/hep.26359","article-title":"Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012","volume":"57","author":"Runyon","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2017.05.041_bib95","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11255-010-9725-8","article-title":"Terlipressin in hepatorenal syndrome: a systematic review and meta-analysis","volume":"43","author":"Dobre","year":"2011","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.cgh.2017.05.041_bib96","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/039139880903200303","article-title":"Terlipressin for hepatorenal syndrome: a meta-analysis of randomized trials","volume":"32","author":"Fabrizi","year":"2009","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.cgh.2017.05.041_bib97","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S2468-1253(16)30157-1","article-title":"Comparative efficacy of pharmacological strategies for management of type 1 hepatorenal syndrome: a systematic review and network meta-analysis","volume":"2","author":"Facciorusso","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2017.05.041_bib98","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/apt.13912","article-title":"Systematic review with meta-analysis: vasoactive drugs for the treatment of hepatorenal syndrome type 1","volume":"45","author":"Gifford","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2017.05.041_bib99","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/hep.23286","article-title":"Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome","volume":"51","author":"Gluud","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2017.05.041_bib100","first-page":"CD005162","article-title":"Terlipressin for hepatorenal syndrome","volume":"9","author":"Gluud","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cgh.2017.05.041_bib101","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MEG.0000000000000537","article-title":"Terlipressin versus noradrenaline in the treatment of hepatorenal syndrome: systematic review with meta-analysis and full economic evaluation","volume":"28","author":"Mattos","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2017.05.041_bib102","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/j.1440-1746.2009.06132.x","article-title":"Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a meta-analysis of randomized controlled trials","volume":"25","author":"Sagi","year":"2010","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2017.05.041_bib103","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2007.04.010","article-title":"Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study","volume":"47","author":"Alessandria","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2017.05.041_bib104","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.27709","article-title":"Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: a randomized trial","volume":"62","author":"Cavallin","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2017.05.041_bib105","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/liv.12179","article-title":"Noradrenaline vs terlipressin in the treatment of type 2 hepatorenal syndrome: a randomized pilot study","volume":"33","author":"Ghosh","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2017.05.041_bib106","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0168-8278(98)80151-7","article-title":"Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome","volume":"29","author":"Hadengue","year":"1998","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2017.05.041_bib107","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","article-title":"Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study","volume":"134","author":"Martin-Llahi","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2017.05.041_bib108","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s10620-007-9919-9","article-title":"Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome","volume":"53","author":"Neri","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2017.05.041_bib109","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","article-title":"A\u00a0randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2017.05.041_bib110","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/j.1572-0241.2008.01828.x","article-title":"An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response","volume":"103","author":"Sharma","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.05.041_bib111","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jhep.2012.01.012","article-title":"Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: a randomized study","volume":"56","author":"Singh","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2017.05.041_bib112","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1440-1746.2003.02934.x","article-title":"Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial","volume":"18","author":"Solanki","year":"2003","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2017.05.041_bib113","first-page":"764","article-title":"Noradrenalin versus the combination of midodrine and octreotide in patients with hepatorenal syndrome: randomized clinical trial","volume":"3","author":"Tavakkoli","year":"2012","journal-title":"Int J Prev Med"},{"key":"10.1016\/j.cgh.2017.05.041_bib114","first-page":"1946","article-title":"Efficacy of Terlipressin and Albumin in the treatment of hepatorenal sydrome.","volume":"12","author":"Silawat","year":"2011","journal-title":"World Appl Sci J"},{"key":"10.1016\/j.cgh.2017.05.041_bib115","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1016\/j.jceh.2013.02.242","article-title":"Noradrenaline is equally effective as terlipressin in reversal of type 1 hepatorenal syndrome: a randomized prospective study","volume":"1","author":"Indrabi","year":"2013","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.cgh.2017.05.041_bib116","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.14309\/00000434-201210001-00418","article-title":"Role of terlipressin and albumin combination versus albumin alone in hepatorenal syndrome","volume":"107","author":"Zafar","year":"2012","journal-title":"Am J Gastroentreol"},{"key":"10.1016\/j.cgh.2017.05.041_bib117","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1053\/j.gastro.2016.02.026","article-title":"Terlipressin plus albumin is more effective than albumin alone in improving renal function in patients with cirrhosis and hepatorenal syndrome type 1","volume":"150","author":"Boyer","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2017.05.041_bib118","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/apt.14052","article-title":"Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT-0401 and REVERSE randomised clinical studies","volume":"45","author":"Sanyal","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2017.05.041_bib119","first-page":"123","article-title":"Efficacy of terlopressin in treatment of liver cirrhosis with hepatorenal syndrome","volume":"7","author":"Yang","year":"2001","journal-title":"J\u00a0Intern Intensive Med"},{"key":"10.1016\/j.cgh.2017.05.041_bib120","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1053\/jhep.2003.50276","article-title":"Octreotide in hepatorenal syndrome: a randomized, double-blind, placebo-controlled, crossover study","volume":"38","author":"Pomier-Layrargues","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2017.05.041_bib121","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jceh.2015.08.003","article-title":"Randomized controlled trial comparing the efficacy of terlipressin and albumin with a combination of concurrent dopamine, furosemide, and albumin in hepatorenal syndrome","volume":"5","author":"Srivastava","year":"2015","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.cgh.2017.05.041_bib122","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1081\/JDI-200035988","article-title":"The clinical course of patients with type 1 hepatorenal syndrome maintained on hemodialysis","volume":"26","author":"Capling","year":"2004","journal-title":"Ren Fail"},{"key":"10.1016\/j.cgh.2017.05.041_bib123","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/08860229509026250","article-title":"Risk factors and outcome of 107 patients with decompensated liver disease\u00a0and acute renal failure (including 26 patients with hepatorenal syndrome): the role of hemodialysis","volume":"17","author":"Keller","year":"1995","journal-title":"Ren Fail"},{"key":"10.1016\/j.cgh.2017.05.041_bib124","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1440-1746.2004.03471.x","article-title":"Which patients benefit from hemodialysis therapy in hepatorenal syndrome?","volume":"19","author":"Witzke","year":"2004","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2017.05.041_bib125","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/hep.26185","article-title":"Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial","volume":"57","author":"Banares","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2017.05.041_bib126","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/lv.2000.6355","article-title":"Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial","volume":"6","author":"Mitzner","year":"2000","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2017.05.041_bib127","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1053\/gast.2002.37073","article-title":"Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis","volume":"123","author":"Gines","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2017.05.041_bib128","unstructured":"Organ Procurement and Transplantation Network. Data. Available\u00a0at: https:\/\/optn.transplant.hrsa.gov\/data\/. Accessed: January 23, 2017."},{"key":"10.1016\/j.cgh.2017.05.041_bib129","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/lt.24488","article-title":"Predicting renal recovery after liver transplant with severe pretransplant subacute kidney injury: the impact of warm ischemia time","volume":"22","author":"Laskey","year":"2016","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2017.05.041_bib130","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1111\/j.1600-6143.2012.04182.x","article-title":"Outcomes and native renal recovery following simultaneous liver-kidney transplantation","volume":"12","author":"Levitsky","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cgh.2017.05.041_bib131","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1002\/hep.27346","article-title":"Plasma protein biomarkers enhance the clinical prediction of kidney injury recovery in patients undergoing liver transplantation","volume":"60","author":"Levitsky","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2017.05.041_bib132","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2215\/CJN.09600912","article-title":"Short-term pretransplant renal replacement therapy and renal nonrecovery after liver transplantation alone","volume":"8","author":"Sharma","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.cgh.2017.05.041_bib133","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/lt.24049","article-title":"The outcome of patients with cirrhosis and type-1 hepatorenal syndrome treated with liver transplantation","volume":"21","author":"Wong","year":"2015","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2017.05.041_bib134","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/TP.0b013e3182449161","article-title":"Evaluation of native kidney recovery after simultaneous liver-kidney transplantation","volume":"93","author":"Francis","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.cgh.2017.05.041_bib135","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/ajt.13102","article-title":"Share 35: a liver in time saves lives?","volume":"15","author":"Feng","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cgh.2017.05.041_bib136","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/ajt.13631","article-title":"Simultaneous liver-kidney allocation policy: a proposal to optimize appropriate utilization of scarce resources","volume":"16","author":"Formica","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cgh.2017.05.041_bib137","unstructured":"A guide to calculating and interpreting the kidney donor profile\u00a0index (KDPI). Available at: https:\/\/optn.transplant.hrsa.gov\/media\/1512\/guide_to_calculating_interpreting_kdpi.pdf. Accessed: January 21,\u00a02017."},{"key":"10.1016\/j.cgh.2017.05.041_bib138","unstructured":"Organ Procurement and Transplantation Network. Policies. Liver-Kidney Allocation. Available at https:\/\/optn.transplant.hrsa.gov\/media\/1200\/optn_policies.pdf#nameddest=Policy_09. Accessed August 19, 2017."}],"updated-by":[{"DOI":"10.1016\/j.cgh.2018.03.038","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000}}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356517306729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356517306729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T15:29:27Z","timestamp":1647098967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356517306729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":138,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1542356517306729"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2017.05.041","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.cgh.2018.03.038","asserted-by":"object"}]},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New Developments in Hepatorenal Syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2017.05.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the AGA Institute","name":"copyright","label":"Copyright"}]}}